Ivuxolimab, CAS 2128729-41-7

Product Description: Ivuxolimab is an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody. OX40 is a costimulatory receptor expressed on activated CD4+ and CD8+ T cells. Ivuxolimab shows antitumor activity, with potential immunostimulatory activity[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Diab A, et al. A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients with Locally Advanced or Metastatic Cancers. Clin Cancer Res. 2022 Jan 1;28(1):71-83.

CAS Number: 2128729-41-7

Molecular Weight: N/A

Compound Purity: 95.32

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99159-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99159-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK